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DNA methylation at cytosine residues in CpG dinucleotides is a component of epigenetic marks crucial to mammalian development. In
preimplantation stage embryos, a large part of genomic DNA is extensively demethylated, whereas the methylation patterns are faithfully
maintained in certain regions. To date, no enzymes responsible for the maintenance of DNA methylation during preimplantation development have
been identified except for the oocyte form of DNA (cytosine-5)-methyltransferase 1 (Dnmt1o) at the 8-cell stage. Herein, we demonstrate that the
somatic form of Dnmt1 (Dnmt1s) is present in association with chromatin in MII-stage oocytes as well as in the nucleus throughout preimplantation
development. At the early one-cell stage, Dnmt1s is asymmetrically localized in the maternal pronuclei. Thereafter, Dnmt1s is recruited to the
paternal genome during pronuclear maturation. During the first two cell cycles after fertilization, Dnmt1s is exported from the nucleus in the G2
phase in a CRM1/exportin-dependent manner. Antibody microinjection and small interfering RNA-mediated knock-down decreases methylated
CpG dinucleotides in repetitive intracisternal A-type particle (IAP) sequences and the imprinted gene H19. These results indicate that Dnmt1s is
responsible for the maintenance methylation of particular genomic regions whose methylation patterns must be faithfully maintained during
preimplantation development.
© 2007 Elsevier Inc. All rights reserved.Keywords: DNA methylation; DNA methyltransferase; Preimplantation development; Genomic imprinting; Nucleocytoplasmic shuttlingIntroduction
DNA methylation at cytosine residues in CpG dinucleotides
is a component of epigenetic marks crucial to mammalian
development (Jaenisch and Bird, 2003; Li, 2002; Reik et al.,
2001). After fertilization, the zygote undergoes extensive deme-
thylation of genomic DNA (Dean et al., 2003; Morgan et al.,
2005; Santos and Dean, 2004). Genomic DNA of paternal
origin is actively demethylated within several hours after fertil-
ization, whereas the oocyte-derived maternal genome is thought
to be passively demethylated, resulting in a parental asymmetry
in epigenetic marks (Mayer et al., 2000; Oswald et al., 2000;⁎ Corresponding author. Fax: +81 3 5684 4958.
E-mail address: yuki-tky@umin.net (Y. Kurihara).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.10.033Rougier et al., 1998). De novo and maintenance DNA
methylation throughout the genome is restored around the
time of implantation to establish tissue-specific epigenetic
states. As for germline development, highly methylated pri-
mordial germ cells migrate to the genital ridge and then undergo
loss and reacquisition of methylation. Thus, two rounds of
demethylation/remethylation events constitute an epigenetic
cycle in mammals.
Contrary to the genome-wide loss of DNA methylation,
methylation states of certain sequences are well preserved
during preimplantation development. For example, the mono-
allelic methylation of imprinted genes such as H19 and Snrpn
must be faithfully maintained for normal development (Doherty
et al., 2002; Tremblay et al., 1997; Warnecke et al., 1998). The
intracisternal A-type particle (IAP), a repetitive sequence of
retrotransposon, is also resistant to demethylation in preim-
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methylation of these genes is important for preventing their
deregulated activation, which may lead to deleterious con-
sequences such as growth abnormalities and tumorigenesis
(Egger et al., 2004; Yoder et al., 1997). However, the mecha-
nism distinguishing methyl-CpG-containing sequences to be
demethylated versus those to be maintained in preimplantation
embryos remains unknown.
Three enzymes with DNA (cytosine-5)-methyltransferase
(Dnmt) activity have been identified in mammals (Bestor,
2000). Dnmt1, a large protein with a molecular mass of
190 kDa, predominantly catalyzes maintenance methylation
via binding to proliferating cell nuclear antigen (PCNA) in
replication foci during the S phase (Bestor et al., 1988;
Chuang et al., 1997; Leonhardt et al., 1992). Two other
enzymes, Dnmt3a and Dnmt3b, are mainly responsible for de
novo methylation that establishes a new DNA methylation
state (Okano et al., 1999, 1998). Inactivation of both Dnmt3a
and Dnmt3b results in defective de novo methylation in
embryonic stem cells and early embryos but has no
discernable effect on the maintenance of preexisting methyla-
tion patterns in postimplantation embryos, indicating that
virtually all DNA methylation is maintained by Dnmt1 during
postimplantation development (Li et al., 1992; Okano et al.,
1999).
Unfertilized oocytes and preimplantation embryos are cha-
racterized by the presence of Dnmt1o, an isoform of Dnmt1
(Mertineit et al., 1998). Dnmt1o is distinct from the conven-
tional Dnmt1 expressed in most somatic cells (Dnmt1s) in that it
uses the oocyte-specific 5′ exon, resulting in the formation of an
N-terminally truncated protein with a molecular mass of
175 kDa (Mertineit et al., 1998). During preimplantation deve-
lopment, Dnmt1o protein is translated from oocyte-derived
mRNA and is actively retained in the cytoplasm except at the
eight-cell stage, when Dnmt1o is transiently translocated to the
nucleus (Cardoso and Leonhardt, 1999; Doherty et al., 2002;
Howell et al., 2001; Mertineit et al., 1998; Ratnam et al., 2002)
Mice homozygous for the Dnm1o-specific knockout allele were
normal, but most heterozygotes from homozygous females were
embryonic lethal with a partial loss of methylation at imprinted
loci (Howell et al., 2001). In contrast, no Dnmt1s protein has
been detected in oocytes and preimplantation embryos,
although its transcripts are present (Cardoso and Leonhardt,
1999; Ratnam et al., 2002). These findings have led to the
conclusion that Dnmt1o is the only known form of maintenance
methyltransferase present in preimplantation embryos and that,
except at the eight-cell stage, methylation patterns must be
maintained by as yet unknown enzymes (Howell et al., 2001;
Ratnam et al., 2002).
Here we demonstrate that Dnmt1s protein is present during
preimplantation development. Characteristically, the nuclear
localization in 1- and 2-cell stage embryos appears to be con-
trolled by a CRM1/exportin-mediated nucleocytoplasmic
shuttling. Furthermore, inactivation of Dnmt1s in preimplanta-
tion embryos revealed that it functions as a maintenance DNA
methyltransferase for certain genomic regions including im-
printed and repetitive genes.Materials and methods
Collection of oocytes and embryos
Female ICR mice (8–10 weeks old) were superovulated with intraper-
itoneal injections of 5 IU of pregnant mare serum gonadotropin (PMSG;
Teikoku Hormone Mfg.) and, 48 h later, 5 IU of human chorionic gonadotropin
(hCG; Teikoku Hormone Mfg.). Oocytes were recovered from the oviducts
20 h after hCG injection, and cumulus cells were extensively dispersed with
1 mg/ml hyaluronidase (Sigma). Preimplantation embryos were obtained from
superovulated females mated to ICR males on appropriate days for each
cleavage stage. To obtain one-cell embryos at early pronuclear stages, ICSI or
in vitro fertilization (IVF) was performed on unfertilized oocytes collected as
above and sperm obtained from ICR males according to standard procedures.
Embryos were cultured in KSOM medium at 37 °C in humidified air
containing 5% CO2.
Plasmids
The mouse Dnmt1s cDNA was cloned by RT-PCR on total RNA from
the mouse liver. For glutathione S-transferase (GST) fusion protein, a cDNA
fragment encoding the N-terminal 118 amino acids of Dnmt1s was
subcloned in-frame into the pGEX vector (Amersham Pharmacia Biotech).
For a series of enhanced green fluorescence protein (EGFP)-fusion
constructs, cDNA fragments encompassing the open reading frame of
Dnmt1s and its derivatives were subcloned in-frame into the pEGFP-C2
expression vector (Clontech). Fragments encoding EGFP-Dnmt1 constructs
were then subcloned into pBluescript (Stratagene) or pCRII-TOPO
(Invitrogen) for in vitro transcription. All the constructs were verified by
sequencing.
Antibodies
To generate polyclonal antibody against the N-terminal region of Dnmt1s,
we prepared fusion proteins between GSTand the N-terminal 118 amino acids of
Dnmt1s in Escherichia coli, and purified them using glutathione-coupled
Sepharose beads. The purified GST fusion proteins were injected into rabbits.
The antibody, named N48, was affinity-purified using this antigen bound to
Affi-Gel 10 (Bio-Rad).
Cell culture and transfection
NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium
containing 10% fetal calf serum and antibiotics at 37 °C in 5% CO2. For
transfection of small interfering RNA (siRNA), cells were grown to 50–90%
confluence and were treated with mixture of siRNA and OligofectAMINE
reagents (Invitrogen) according to the manufacturer's protocol.
Western blotting
A pool of ∼500 unfertilized oocytes were lysed in PBS containing 1%
Nonidet P-40 and protease inhibitors, and then subjected to 7.5% SDS-PAGE
with lysates of NIH3T3 cells. The separated proteins were transferred to a nylon
membrane, which was then pre-treated with 3% bovine serum albumin for
blocking and incubated with the N48 antibody and treated with anti-rabbit IgG
antibody conjugated to horseradish peroxidase (ICN). The protein bands were
visualized using an ECL Plus Western Blotting Detection System (Amersham
Pharmacia Biotech). Then, the membrane was washed and re-blotted with the H-
300 antibody recognizing the C-terminus of Dnmt1 (rabbit, Santa Cruz). The
relative amounts of proteins were estimated by densitometry using the ImageJ
software (NIH).
Immunostaining
Unfertilized oocytes and preimplantation embryos were freed of the zona
pellucida by using acidified Tyrode's medium, fixed for 15 min in 4%
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for 5 min at room temperature. After blocking for 30 min in 5% normal donkey
serum, the samples were incubated in the same solution with the N48 or H-300
antibodies overnight at 4°C. Then, the samples were washed and stained with
the secondary antibodies (FITC- or rhodamine-conjugated donkey anti-rabbit
IgG (Jackson Immunoresearch). Staining with rabbit polyclonal anti-GFP
antibody (MBL) served as negative control. DNA was visualized by staining
with DAPI (1μg/ml) or propidium iodide (50μg/ml). Confocal images were
obtained using a Nikon D-ECLIPSE C1 system.
For semi-quantitative analysis of immunofluorescent signals, the pixel
value/unit was measured for the nuclear and cytoplasmic signals using ImageJ
software (NIH) and the relative nuclear intensity was evaluated by dividing the
pixel value/unit of the nuclear signal by that of the cytoplasmic signal. Data were
analyzed using analysis of variance (ANOVA) and significance was defined as
Pb0.05 (Sheffe's F-test).
RNA preparation and microinjection
Preparation and injection of in vitro transcribed mRNA were performed as
previously described (Aida et al., 2001). Briefly, plasmids containing EGFP-
Dnmt1 fusion constructs were linearized and used as templates for in vitro
transcription employing the T7 MessageMachine kit (Ambion). Synthesized
RNA was further polyadenylated by yeast poly(A) polymerase (Amersham
Biosciences) and resolved in 150 mM KCl with a final concentration of
∼100 ng/μl. The diluted RNAwas filtered, heated at 90 °C for 1 min and cooled
on ice. Then, ∼10 pl of the RNA solution were injected into fertilized eggs or
two-cell embryos through a glass micropipette. Fluorescent images were
obtained and the relative nuclear intensity was evaluated as in the case of
immunostaining.
ICSI with microinjection of antibodies
ICSI was performed as previously described (Kimura and Yanagimachi,
1995). Antibodies were premixed in the sperm suspension to be introduced into
oocytes. Anti-GST antibody served as a negative control.
RNA interference
Chemically synthesized 27-nt siRNA duplexes with no overhang were
commercially obtained (Japan Bio-Service). Two different sequences for
Dnmt1s were selected for the generation of siRNA; the sequences for si290
and si322 corresponded to nucleotides 290–316 and 322–348 of mouse Dnmt1s
(GenBank accession number NM_010066), respectively. Inv322, a siRNA
possessing the inverted sequence of si322, served as a control. Approximately
10 pl of 20 μM siRNA were injected into the cytoplasm of unfertilized eggs,
which were subsequently subjected to in vitro fertilization.
DNA methylation analysis
About 20–40 embryos were embedded in one agarose droplet, which was
then treated with sodium bisulfite for cytosine modification as described (Olek et
al., 1996). Each sample was subdivided into 2–3 tubes and was subjected to
two-round nested PCR analysis. PCR primers were synthesized to analyze the
methylation status of the H19 upstream DMD (GenBank accession number
U19619, nucleotides 1304–1726) (Tremblay et al., 1997) and the LTR of IAP
(GenBank accession number M17551, nucleotides 48–305) (Lane et al., 2003).
Amplified PCR products were subcloned into PCRII-TOPO vector and were
sequenced. Bisulfite reaction was considered complete when more than 99% of
the cytosines were converted to thymines. For IAP, 3–5 clones were sequenced
from each PCR template. For H19, paternal alleles were distinguished by a
single polymorphism in the analyzed region (Tremblay et al., 1997) and one
representative sequence (the youngest number of several sequenced clones) was
adopted from each template. Primer sequences are available on request.
Statistical analysis was performed by Mann–Whitney's U-test for two-
group comparison of antibody-injected embryos, and by one-way ANOVA,
Sheffe's post hoc analysis for three-group comparison of siRNA-injected
embryos. P values less than 0.05 were considered significant.Results
Dnmt1s protein is present in mouse unfertilized oocytes and
preimplantation embryos
To test the current assumption that Dnmt1s mRNA is not
translated into proteins during preimplantation development,
we first raised a rabbit polyclonal antibody against the N-
terminal region specific for the Dnmt1s isoform (Fig. 1A). This
antibody, named N48, was capable of detecting a single band
with a molecular mass of ∼190 kDa in Western blot of MII-
stage unfertilized oocyte extracts as well as NIH3T3 cell ex-
tracts (Fig. 1B). For comparison, the membrane was re-probed
with H-300, an antibody recognizing the C-terminal region of
both Dnmt1s and Dnmt1o. Signal intensity was adjusted by
changing blotting condition and exposure times to allow com-
parison of the amounts of Dnmt1s and Dnmt1o as below. As
expected, H-300 detected ∼175-kDa Dnmt1o in unfertilized
oocytes and ∼190 kDa-Dnmt1s in NIH3T3 cells (Fig. 1B).
Using the signal intensities from different volumes (1× and 4×)
of NIH3T3 extracts as references, Dnmt1s was estimated to be
∼2000-fold less abundant than Dnmt1o in MII-stage unferti-
lized oocytes. The presence of Dnmt1s was also confirmed
with another Dnmt1s-specific antibody UPT82 (Ratnam et al.,
2002) (data not shown). Dnmt1s was also detected in morula-
stage embryos by both N48 and UPT82 antibodies (data not
shown).
To determine the localization of Dnmt1s, MII-stage
unfertilized oocytes were stained with the N48 antibody. In
contrast to the cytoplasmic distribution of Dnmt1o as shown by
staining with H-300, Dnmt1s signals were exclusively
localized to meiotic chromosomes (Fig. 1C). After fertilization,
growing preimplantation embryos showed the presence of
Dnmt1s in the nucleus until the blastocyst stage, whereas
Dnmt1o signals were predominantly detected in the cytoplasm
(Fig. 1D). Although previous reports showed nuclear translo-
cation of Dnmt1o at the 8-cell stage (Doherty et al., 2002;
Howell et al., 2001), H-300 antibody detected only weakly the
nuclear Dnmt1o possibly due to differences in epitope recog-
nition. These results indicate that Dnmt1s proteins are trans-
lated and localized to the nucleus during preimplantation deve-
lopment, whereas Dnmt1o reciprocally distributes throughout
the cytoplasm.
Differential localization of Dnmt1s between paternal and
maternal pronuclei
To investigate the dynamics of Dnmt1s localization from
fertilization to the first cleavage, mouse one-cell embryos were
collected 2 and 5 h after intracytoplasmic sperm injection
(ICSI), and 21, 27 and 30 h after hCG injection with natural
crossbreeding. Embryos were then stained with N48 antibody
and propidium iodide (PI). According to the size and location of
the pronuclei in the cytoplasm, samples were assigned to one of
the pronuclear stages, PN0–PN5 (Adenot et al., 1997; Santos et
al., 2002). Each sampling time approximately corresponded to
PN0, PN1–2, PN3–4, PN5 and M-phase, respectively.
Fig. 1. Presence and localization of Dnmt1s in mouse unfertilized eggs and preimplantation embryos. (A) Structures of Dnmt1 isoforms and locations of epitopes
recognized by two different antibodies; N48 and H-300. PBD, PCNA binding domain; TS, DNA replication foci-targeting sequence; PBHD, polybromo homology
domain; CD, catalytic domain. (B) Western blotting of extracts from mouse unfertilized eggs (Uf) and NIH3T3 cells, probed with N48 and then reprobed with H-300.
N48 detected only the 190 kDa Dnmt1s, whereas H-300 detected both 190 kDa Dnmt1s and 175 kDa Dnmt1o. Signals from different volumes (1× and 4×) of NIH3T3
extracts were used for comparison of relative amounts of Dnmt1 isoforms. (C) Immunostaining of mouse MII-stage unfertilized eggs with N48 and H-300. DNAwas
visualized by PI staining. For staining with N48 and PI, the PI staining image was superimposed on the corresponding light microscopic image. Dnmt1s colocalizes
with meiotic chromosomes, as seen in yellow (merged image), whereas Dnmt1o distributes reciprocally in the cytoplasm. Scale bars indicate 20 μm. (D)
Immunostaining of mouse preimplantation embryos. Dnmt1s is detected in the nuclei, whereas Dnmt1o is predominantly distributed in the cytoplasm.
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polar body is eliminated upon the completion of meiosis. At this
stage, Dnmt1s was exclusively detected in association with the
maternal genome (Fig. 2A). As maturation of the pronuclei
proceeded from PN1 to PN4, faint Dnmt1s signals alsoappeared in the paternal pronucleus, although at lower intensity
than that of the maternal pronucleus (Figs. 2B, C). In three
embryos at PN3–4, intense Dnmt1s signals were detected in the
paternal pronucleus in a punctate pattern (Fig. 2D). These
findings indicate that Dnmt1s is recruited to the paternal
Fig. 2. Localization of Dnmt1s in one- and two-cell stage embryos. (A–F) Representative immunofluorescent images of one-cell embryos stained with the N48
antibody at different pronuclear stages. DNAwas visualized by PI staining. The identity of the pronuclei was determined by their size and position relative to the polar
body. At PN0, Dnmt1s is detected only in association with the maternal genome (A). Dnmt1s is thereafter localized predominantly in the maternal pronucleus until
PN5 (B–D). Dnmt1 is also detected in the paternal nucleus, but the signals are quite faint (B, C). At PN3–4, some embryos show intense Dnmt1s signals in the paternal
pronucleus in a punctate pattern (D). At PN5, Dnmt1s largely disappears from the pronuclei (E). At syngamy, Dnmt1 again colocalizes to the chromosome (F). (G)
Control staining with anti-GFP antibody. (H–M) Representative immunofluorescent images of two-cell embryos stained with the N48 antibody at different cell cycle
phases. Dnmt1 localizes in the nucleus through the G1 (H) to the S phase (I). Dnmt1s signals in the S phase show a punctate pattern. Then, Dnmt1s in the nucleus was
largely decreased in the G2 phase (J). In some cases, Dnmt1s signals were absent from the nucleus in either (K) or both (L) of the blastomeres in G2. In the M phase,
Dnmt1 again localizes in close association with the chromosomes (M). M, maternal pronucleus; P, paternal pronucleus; PB, polar body. Scale bars indicate 20 μm.
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4. At PN5, Dnmt1s signals in the maternal pronucleus were
reduced to the paternal pronucleus level (Fig. 2E). During
mitosis, Dnmt1s again colocalized intensely to the chromo-
somes (Fig. 2F). Staining with anti-GFP antibody as negative
control gave little signals (Fig. 2G).
Dynamic changes in nuclear localization of Dnmt1s in early
preimplantation embryos
In addition to asymmetric localization of Dnmt1s in the
pronuclei, immunostaining analysis revealed dynamic changes
in this protein during pronuclear maturation through to the first
cleavage. The pronuclear staging has been shown to correlate
with cell cycle phases; PN1–2 embryos are in G1, PN3–4
embryos are largely in S, and PN5 embryos are mostly in G2
(Adenot et al., 1997). Significantly, the punctate pattern of
Dnmt1s signals in PN3–4 embryos is very similar to that
associated with the DNA replication foci in cultured somatic
cells in middle and late S phase (Leonhardt et al., 1992; Liu et al.,Fig. 3. Dynamic changes in the localization of EGFP-Dnmt1 mutant proteins. (A) St
Dnmt1s (B), EGFP-Dnmt1o (C) and EGFP-Dnmt1(112–263) (D) were microinjected
microscopy. Shown are representative embryos expressing each EGFP-Dnmt1 muta1998). Therefore, the dynamics of localization in one-cell
embryos suggest that Dnmt1 may be recruited and sustained in
the pronucleus during the G1 to S phases, and then excluded
from the pronucleus in the G2 phase. To test this possibility at
later stages, we examined the dynamics of Dnmt1s localization
in two-cell embryos.
It has been reported that, during the second cell cycle, the
G1, S and G2 phases last about 2, 6–7 and 14 h, respectively
(Moore et al., 1996). On the basis of this report, two-cell
embryos were collected 1 h (G1), 6 h (S) and 12–20 h (G2) after
the first cleavage and stained with N48 antibody and PI. Dnmt1s
was diffusely distributed in the nucleoplasm in the G1 phase
(Fig. 2H). In the S phase, Dnmt1s signals showed a punctate
pattern in the nucleus (Fig. 2I), as seen in somatic cells in the
same phase. In contrast, many embryos exhibited significantly
reduced Dnmt1s signals in the nucleus during the G2 phase
(Fig. 2J). In some cases, Dnmt1s signals were absent from the
nucleus in either or both of the blastomeres (Figs. 2K, L),
indicating the transient disappearance of Dnmt1s from the
nucleus during the G2 phase. During mitosis, Dnmt1s wasructures of EGFP-Dnmt1 mutant proteins. (B–D) In vitro transcripts for EGFP-
into one-cell embryos and fluorescent images were serially obtained by confocal
nt protein. Time is in hours after mRNA injection. Scale bars indicate 20 μm.
Fig. 4. Effects of leptomycin B on the dynamics of EGFP-Dnmt1s localization. (A) In vitro transcripts for EGFP-Dnmt1s were microinjected into one-cell embryos.
Embryos were then cultured in the presence of leptomycin B. Fluorescent images were serially obtained by confocal microscopy. Time is in hours after mRNA
injection. Scale bars indicate 20 μm. (B) Comparison of the relative nuclear intensity of EGFP-Dnmt1s signals after mRNA injection into one-cell embryos in the
absence (open columns) and presence (filled columns) of leptomycin B. The columns and bars represent means±S.D. of 4–6 measurements per data point. *Pb0.05,
†Pb0.01. (C, D) In vitro transcripts for EGFP-Dnmt1s were microinjected into one-half of two-cell embryos. Embryos were then cultured in the absence (C) and
presence (D) of leptomycin B. Fluorescent images were serially obtained by confocal microscopy. Time is in hours after mRNA injection. Scale bars indicate 20 μm.
(E) Comparison of the relative nuclear intensity of EGFP-Dnmt1s signals after mRNA injection into one-half of two-cell embryos in the absence (open columns) and
presence (filled columns) of leptomycin B. The columns and bars represent means±S.D. of 4–6 measurements per data point. *Pb0.005.
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did not completely coincide with the chromosomes (Fig. 2M).
Nuclear-cytoplasmic shuttling of GFP-Dnmt1s in early
preimplantation embryos
To confirm the dynamics of nuclear Dnmt1s localization and
clarify the underlying mechanism, we constructed plasmids
encoding fusion proteins of EGFP with full-length Dnmt1s orFig. 5. Effects of antibody microinjection on DNA methylation states in preimplanta
injected embryos at the eight-cell and morula stages. (B) Bisulfite sequencing profi
morula stage. Open and filled circles represent unmethylated and methylated CpGs
percentage of methylated CpGs is shown below each group of clones.its mutants (Fig. 3A), and injected their in vitro transcripts into
early stage embryos. When EGFP-Dnmt1s mRNAwas injected
into ∼200 one-cell embryos 24–26 h after hCG injection, 36
embryos showed EGFP signals in their pronuclei 1–2 h after
injection and 11 embryos reached the two-cell stage with
nuclear EGFP signals. Disappearance of EGFP-Dnmt1s from
the pronuclei at PN5 could be verified in 8 of the 11 embryos
(Fig. 3B). At the two-cell stage, EGFP signals were again
localized to the nucleus within several hours after the firsttion embryos. (A) Bisulfite sequencing profiles of the LTR of IAP in antibody-
les of the DMD of the paternal H19 allele in antibody-injected embryos at the
, respectively. Each line corresponds to an individual DNA strand. The overall
343Y. Kurihara et al. / Developmental Biology 313 (2008) 335–346cleavage, but had mostly disappeared from the nucleus around
the G2 phase (Fig. 3B), mimicking the behavior of Dnmt1s-
immunoreactivity in embryos at the same stage. When EGFP-
Dnmt1o mRNA was injected into one-cell embryos, EGFP-
Dnmt1o protein was also localized to the nucleus as in case of
EGFP-Dnmt1s (Fig. 3C). In contrast, EGFP-fusion protein with
the N-terminal region containing putative nuclear localization
signals (amino acids 112–263) resulted in retention of EGFP
signals in the nucleus (Fig. 3D). These results indicate that the
disappearance of Dnmt1 from the (pro)nucleus is not due to the
presence of EGFP and does not require the Dnmt1s-specific N-
terminal region.
To test whether the decrease in nuclear EGFP signals was
attributable to active nuclear export, embryos were injected withFig. 6. Effects of Dnmt1-targeted siRNAmicroinjection on DNAmethylation states in
siRNAwas verified in NIH 3T3 cells by Western blotting (A) and immunostaining (B
with control and Dnmt1 siRNA, probed with the N48 antibody. DNAwas countersta
injected embryos. (D) Bisulfite sequencing profiles of the IAP LTRs in siRNA-injected
methylated CpGs, respectively. Each line corresponds to an individual DNA strand. TEGFP-Dnmt1s mRNA at the one-cell stage and then treated
with leptomycin B, an inhibitor of CRM1/exportin-mediated
nuclear export. EGFP signals were retained in the nucleus with
high intensity in leptomycin B-treated embryos (Figs. 4A, B).
EGFP-Dnmt1s mRNA was also injected into one-half of two-
cell embryos 1–4 h after the first cleavage. Among ∼220
embryos injected, 22 expressed EGFP-Dnmt1s protein in the
injected half. In all seven embryos that grew to the four-cell
stage within 36 h after the first cleavage, nuclear EGFP-Dnm1s
signals were largely suppressed during the G2 phase, whereas
cytoplasmic EGFP signals were sustained (Fig. 4C). In the
presence of leptomycin B, however, EGFP signals were
retained in the nucleus with high intensity (Fig. 4D). These
results indicate that the decrease in nuclear EGFP-Dnmt1spreimplantation embryos. (A, B) Efficient downregulation of Dnmt1s protein by
) with N48 antibody. (C) Immunostaining analysis of 8–16 cell embryos injected
ined with PI. Dnmt1 expression is effectively knocked-down in Dnmt1 siRNA-
embryos at the morula stage. Open and filled circles represent unmethylated and
he overall percentage of methylated CpGs is shown below each group of clones.
344 Y. Kurihara et al. / Developmental Biology 313 (2008) 335–346during the G2 phase is attributable to CRM1/exportin-
dependent nuclear export.
Microinjection of anti-Dnmt1 antibody affects DNA
methylation patterns
To examine whether Dnmt1s present in preimplantation
embryos is responsible for the maintenance of DNA methyla-
tion during this stage, we evaluated genomic methylation
patterns using two different approaches. First, we performed
ICSI with co-injection of N48, expecting that it might function
as a Dnmt1s-specific neutralizing antibody. In control embryos
injected with anti-GST antibody, the long terminal repeats
(LTR) of IAPs were highly methylated as revealed by bisulfite
sequencing at the eight-cell and morula stages (81% and 82%,
respectively) (Fig. 5A). Injection with N48 antibody resulted in
a significant decrease in DNA methylation of IAPs at the
morula stage (60%, Pb0.05) (Fig. 5A). Similar phenomenon
was observed at the 8-cell stage, although it was not statistically
significant (53%, P=0.064) (Fig. 5A). Notably, some IAP
sequences showed complete or nearly-complete demethylation
in N48-injected embryos, which was consistent with the failure
of DNA methylation maintenance (Fig. 5A). We also analyzed
the effect of N48 injection on the methylation state of the
paternally imprinted H19 gene. To determine the parental
origins of alleles, we injected sperm from M. m. castaneus
males into oocytes from ICR females with N48 or control anti-
GST antibodies. In embryos injected with control antibody, the
differentially methylated domain (DMD) of the H19 gene of the
paternal allele was highly methylated at the morula stage (91%),
whereas that of the maternal allele was mostly demethylated
(7%) (Fig. 5B). In N48-injected embryos, the percentage of
DNA methylation in this region of the paternal allele was
significantly decreased (60%, Pb0.01), whereas that of the
maternal allele was similarly demethylated (4%) (Fig. 5B).
These results indicate the methylated CpGs dinucleotides in the
IAP and H19 gene loci to be decreased by microinjection of
anti-Dnmt1s antibody.
Dnmt1-targeted siRNA affects DNA methylation patterns
To further investigate the role of Dnmt1s in maintenance
methylation, we adopted RNAi-mediated knock-down experi-
ments because Dnmt1s, rather than Dnmt1o, is known to be
actively transcribed during preimplantation development (Rat-
nam et al., 2002 and our unpublished data). siRNA was
designed to target against Dnmt1s mRNA and tested in NIH
3T3 cells. Western blotting (Fig. 6A) and immunostaining with
N48 antibody (Fig. 6B) confirmed the effectiveness of the
siRNA. We then injected Dnmt1s siRNA duplexes into
fertilized eggs at the pronuclear stage and analyzed their effects
on the methylation state of IAPs to test whether the decrease in
DNA methylation induced by antibody injection could be
reproduced by RNAi-mediated Dnmt1s knock-down. Two
independent siRNAs, si290 and si322, against Dnmt1s down-
regulated Dnmt1s expression also in preimplantation embryos,
as revealed by immunostaining (Fig. 6C). Microinjection ofeither Dnmt1s siRNA resulted in significant decreases in DNA
methylation of IAPs at the morula stages (57% and 55%,
Pb0.05 for si290 and si322, respectively), as compared with
that of embryos injected with a control siRNA (83%) (Fig. 6D).
As in N48-injected embryos, some IAP sequences demonstrated
complete or nearly-complete demethylation (Fig. 6D). Taken
together, these results indicate that Dnmt1s synthesized after
fertilization is involved in the maintenance methylation of
certain repetitive sequences and imprinted genes.
Discussion
Fertilization initiates epigenetic reprogramming to establish
totipotency in the early embryo. Large part of the gametic
genome undergoes active or passive DNA demethylation and
chromatin remodeling into a zygotic pattern. In contrast, the
methylation states of some genomic regions including repetitive
sequences and imprinted genes are faithfully maintained during
the same period. Failure to identify the enzyme(s) responsible
for maintenance DNA methylation in the nucleus of preim-
plantation embryos, expect for Dnmt1o at the eight-cell stage,
has hampered the clarification of mechanisms by which the
genomic sequences are selected for demethylation or main-
tenance methylation and epigenetic reprogramming proceeds
precisely.
In the present study, we demonstrated the presence of
Dnmt1s protein in the nuclei of preimplantation embryos. This
finding is quite contrary to previous literature demonstrating
that no Dnmt1s protein is translated from its mRNA during this
period. Very low amounts of Dnmt1s relative to cytoplasmic
Dnmt1o may have prevented it from detection. Especially, the
UPT82 antibody, which can recognize the Dnmt1s-specific N-
terminal region, has been reported to detect Dnmt1s in
preimplantation embryos when Dnmt1s is forcedly expressed
in oocytes (Ratnam et al., 2002), and in 4-,8- and 16-cell
embryos that are missing Dnmt1o (Chung et al., 2003). In the
later case, loss of Dnmt1o is assumed to cause aberrant
expression of Dnmt1s. This apparent discrepancy may be due to
differences in sensitivity of antibodies and/or epitope sites to be
recognized, which might be protected from recognition by
posttranslational modification or complex formation. Indeed, it
has been reported that an antibody which recognizes the
Dnmt1s-specific N-terminal region could detect Dnmt1s protein
in association with mitotic chromatin in somatic cells, while
other antibodies could not detect it (Easwaran et al., 2004),
indicating the detectability of Dnmt1s may be context-
dependent even in the same cells.
Asymmetric distribution of Dnmt1s in the parental genome
may be linked to differential reprogramming processes after
fertilization. Upon fertilization, the paternal genome undergoes
extensive demethylation before the initiation of DNA replica-
tion, whereas the maternal genome is protected from this active
demethylation and completes the second meiosis. Although the
mechanism of active demethylation remains unknown, epige-
netic differences between gametes at fertilization are thought to
contribute to the establishment of this parental asymmetry
(Morgan et al., 2005). The presence of Dnmt1s, together with
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proteins such as HP1β, may protect the maternal genome from
active demethylation. On the other hand, Dnmt1s is absent from
decondensing sperm and is gradually recruited to the paternal
genome during the first cell cycle. This time course is similar to
those of some epigenetic changes such as K9 dimethylation and
K27 trimethylation of histone H3 (Morgan et al., 2005; Santos
et al., 2005). Di/trimethylated H3-K9 and trimethylated H3-K27
are specifically targeted by the chromodomains of HP1 and
polycomb proteins, respectively (Margueron et al., 2005). In
fact, HP1β is also recruited to the paternal genome during a
similar period (Santos et al., 2005). Because HP1β and its
interacting partner SUV39H1 can associate with Dnmt1 (Fuks
et al., 2003), these factors may mediate the recruitment of
Dnmt1s to the paternal genome and cooperate with it in
reestablishing an epigenetic state equivalent to the maternal one.
Immunostaining demonstrates cell cycle-coupled dynamics
of Dnmt1s localization during at least the first two cell cycles.
The effect of leptomycin B on Dnmt1s localization indicates
that nuclear Dnmt1s appears to translocate to the cytoplasm in
the G2 phase via CRM1/exportin-mediated nuclear export. This
phenomenon may be highly characteristic of preimplantation
embryos at this stage, because endogenous and forcedly-
expressed Dnmt1s is localized in the nucleus throughout cell
cycle in somatic cells such as NIH3T3 cells and HeLa cells
(Easwaran et al., 2004, and our unpublished data). Dnmt1
contains a leucine-rich region in its C-terminus, which is close
to the consensus sequence of the nuclear export signal (NES),
which is recognized by CRM1/exportin (Kutay and Guttinger,
2005). This region may act as a functional NES in the G2 phase
of preimplantation embryos.
Interestingly, EGFP-Dnmt1o was also localized to the
nucleus and thereafter translocated to the cytoplasm. We
speculate that the initial localization to the nucleus and
translocation to the cytoplasm thereafter do not require the
Dnmt1s-specific N-terminal region. It also raises a possibility
that de novo-synthesized Dnmt1o may first localize to the
nucleus and may be thereafter sequestered to the cytoplasm by
an active mechanism. It has been previously reported that
Dnmt1o interacts and colocalizes with annexin V (Ohsawa et
al., 1996), a calcium-sensitive phospholipid binding protein
(Schlaepfer et al., 1987). This interaction is postulated to lead to
active sequestration of Dnmt1o in the cytoplasm of unfertilized
oocytes and preimplantation embryos (Doherty et al., 2002).
This may explain the difference in subcellular localization
between Dnmt1s and Dnmt1o.
At present, there is no evidence supporting the relation
between this phenomenon and genome-wide demethylation.
However, it might be possible that the disappearance of Dnmt1s
from the nucleus in G2 decreases the opportunity for this
enzyme to be recruited to hemi-methylated CpG regions or
nuclear complexes containing proteins interactive with it after
the S phase. Indeed, previous reports have demonstrated that
Dnmt1s associates with chromatin (preferentially constitutive
heterochromatin) during the G2 and M phases through a
mechanism different from a replication dependent one in the S
phase (Easwaran et al., 2004). Thus, the depletion of nuclearDnmt1s in G2 may be related to the limited maintenance
methylation during preimplantation development.
Decreases in methylated CpG dinucleotides in the LTR of
IAPs and the paternal allele of H19 in response to microinjec-
tion of N48 or Dnmt1 siRNA suggest nuclear-localized Dnmt1s
to be involved in maintenance methylation during preimplanta-
tion development. The presence of Dnmt1s in the nucleus and
its function in maintenance methylation appear to compensate
for the limited role of Dnmt1o, which apparently translocates to
the nucleus only at the eight-cell stage (Howell et al., 2001),
during preimplantation development. In preimplantation
embryos, methylation states are maintained only in limited
genomic sequences, in contrast to the situation in somatic cells.
Taken together with the observation that the localization of
Dnmt1s fluctuates via nucleocytoplasmic shuttling in preim-
plantation embryos, these findings indicate that this character-
istic behavior of Dnmt1s may restrict its recruitment to certain
genomic regions, allowing large portions of the genomic DNA
to be demethylated. The mechanism by which Dnmt1s is
recruited to particular regions in the ubiquitously methylated
genome of preimplantation embryos should be further
investigated.
In the present study, about 50% to 60% of CpG
dinucleotides in the LTR of IAPs and the paternal allele of
H19 remained methylated after microinjection of N48 or
Dnmt1 siRNA. This partial demethylation may be due to the
presence of Dnmt1o and/or incomplete inactivation of Dnmt1s
with the methods used in this study. In our preliminary
experiment, however, embryos injected with Dnmt1 siRNA
tended to show growth retardation after implantation, as
compared to control siRNA-injected embryos (data not
shown). This result may support the idea that Dnmt1s activity
in preimplantation embryos is required for normal postimplan-
tation development, although it may also be possible that the
effect of injected siRNA was retained after implantation to
affect the growth thereafter.
Recently, Sasaki's group established oocyte-specific Dnmt1
knockout mice and demonstrated that Dnmt1, but not Dnmt3a
and 3b, is mostly responsible for maintenance DNA methyla-
tion during preimplantation development (Ryutaro Hirasawa
and Hiroyuki Sasaki, personal communication). Taken
together with only partial reduction in DNA methylation in
Dnmt1o-specific knockout embryos reported previously
(Howell et al., 2001), their results are consistent with us in
that Dnmt1s may compensate the absence of Dnmt1o in the
nucleus except for the 8-cell stage during preimplantation
development. Dnmt1s-specific gene knockout is expected to
further clarify this issue.
In conclusion, the present study has revealed the presence of
Dnmt1s in the nucleus and its nucleocytoplasmic shuttling in
preimplantation embryos. Inactivation of Dnmt1s by micro-
injection of Dnmt1s-specific antibody and siRNA resulted in
decreases of methylated CpG dinucleotides in the genomic
regions whose methylation patterns must be maintained after
fertilization. These findings may contribute to the under-
standing of the mechanism underlying epigenetic regulation
during preimplantation development.
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